1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744
https://www.mirion.com
Sector(s): Industrials
Industry: Specialty Industrial Machinery
Full-time employees: 2,800
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Thomas D. Logan | Founder, Medical Group President, CEO & Director | 1.87M | N/A | 1961 |
Mr. Brian Schopfer | Chief Financial Officer | 1.14M | N/A | 1985 |
Mr. Loic Eloy | Group President of Technologies | 626.84k | N/A | 1977 |
Mr. Christopher Moore CPA | Chief Accounting Officer & Principal Accounting Officer | N/A | N/A | 1972 |
Mr. James Cocks | Chief Technology Officer | N/A | N/A | N/A |
Mr. Alex Gaddy | SVP of Strategy, IR & Treasurer | N/A | N/A | N/A |
Ms. Emmanuelle Lee | Executive VP, General Counsel, Secretary & Chief Legal Officer | N/A | N/A | N/A |
Erin Schesny | Chief Marketing Officer | N/A | N/A | N/A |
Ms. Alison Ulrich | Chief Human Resources Officer | N/A | N/A | N/A |
Mr. Bertrand Duban | President of Nuclear Medicine | N/A | N/A | N/A |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Mirion Technologies, Inc.’s ISS governance QualityScore as of 1 May 2024 is 4. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 6; Compensation: 4.